Cartesian Therapeutics
RNAC
#8958
Rank
ยฃ0.14 B
Marketcap
ยฃ4.69
Share price
4.24%
Change (1 day)
-15.11%
Change (1 year)

Earnings for Cartesian Therapeutics (RNAC)

Earnings in 2026 (TTM): -ยฃ39.43 Million

According to Cartesian Therapeutics's latest financial reports the company's current earnings are ยฃ1.47 Million. In 2025 the company made an earning of -ยฃ37.47 Million a decrease over its 2024 earnings that were of -ยฃ20.75 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cartesian Therapeutics from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ39.43 Million5.24%
2025 -ยฃ37.47 Million80.63%
2024 -ยฃ20.75 Million-88.5%
2023 -ยฃ0.19 Billion-724%
2022 ยฃ28.89 M-649.67%
2021 -ยฃ5.26 Million-89.78%
2020 -ยฃ51.47 Million25.06%
2019 -ยฃ41.15 Million-15.68%
2018 -ยฃ48.81 Million-0.43%
2017 -ยฃ49.02 Million83.41%
2016 -ยฃ26.73 Million44.3%
2015 -ยฃ18.52 Million